From Name

From Email

To Name

To Email

Message

How to lower drug prices without killing research and development

from Newsweek

How to lower drug prices without killing research and development Newsweek For instance, Gilead recently announced that Remdesivir, a drug originally developed for hepatitis C that has been shown to be effective in speeding up the recovery time for COVID-19, will be priced at $3,120. In explaining its pricing, Gilead pointed out that given the cost of extended hospitalization (estimates for COVID-19 patients are around $12,000 per day), the price is justified based on the value it provides. READ MORE

more